Development Characteristics and Trends of Smart Healthcare in China: A 20-Year Patentometric Analysis
This patentometric analysis of 26,189 global patents from 2006 to 2025 reveals China's dominance in smart healthcare innovation with a 75% share, while highlighting critical structural imbalances characterized by a heavy focus on hardware, weak algorithmic and Traditional Chinese Medicine integration, and a need for policy shifts toward balanced value-chain development.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Imagine a world where your health is not just a record kept in a doctor's file, but a continuous stream of data flowing from a watch on your wrist, a sensor in your home, and an algorithm that can spot illness before you feel a symptom. This is the promise of smart healthcare, a field where artificial intelligence meets medicine to create a system that is faster, more precise, and available to more people. For countries around the globe, this is not just a futuristic idea but a strategic priority, a way to solve the growing strain on hospitals and to improve the quality of life for an aging population. At the heart of this transformation is the invention of new tools and methods, protected by patents, which serve as a map of where innovation is happening and where it is missing.
To understand how this field is evolving, a team of researchers from several major Chinese medical institutions decided to look at the global landscape of these inventions over the last twenty years. They did not just count how many patents were filed; they treated the collection of documents as a massive dataset to be mined for patterns. By examining nearly twenty-six thousand patents filed between 2006 and 2025, they traced the journey of smart healthcare from its early days to its current state. Their goal was to see who is building these technologies, what kinds of problems they are solving, and whether the progress is balanced across the different needs of the medical world.
The researchers found that China has become the undisputed leader in the sheer volume of these inventions. Out of the nearly twenty-six thousand patents they analyzed from offices around the world, three-quarters came from China. This dominance has grown steadily over time; in the early years of the study, China accounted for less than half of the global total, but by the final years, it was responsible for nine out of every ten new patents. This surge was not a sudden explosion but a steady climb, with the number of filings rising from a few hundred a year in the mid-2000s to a peak of nearly three thousand in 2021. While the total number of filings has dipped slightly in the most recent years, the researchers suggest this indicates a shift from simply making more patents to making better, more refined ones.
When the team looked at who was doing the inventing, a clear picture emerged of an ecosystem driven by business rather than the bedside. Companies were the primary creators, holding nearly half of all the patents, followed closely by individual inventors. Universities contributed a smaller share, and hospitals, where the actual medical care happens, accounted for only a tiny fraction of the output. This suggests that while the industry is booming with commercial products, the people who treat patients every day are not yet fully engaged in the patenting process, leaving a gap between clinical needs and the inventions being brought to market.
The nature of these inventions tells a story of a field that is still heavily focused on physical tools. The researchers categorized the patents by what they actually did, finding that the majority were dedicated to hardware: devices for surgery, tools for delivering medicine, and machines for monitoring patients. These physical inventions made up the vast majority of the work. In contrast, the patents for the "brain" of the system—the software, the artificial intelligence algorithms, and the data processing methods—were far fewer. While the industry is moving toward digital solutions, the foundation remains built on metal and plastic. This imbalance is partly due to the rules of patent law, which make it difficult to protect a pure computer program without tying it to a specific physical device.
The researchers also mapped out the specific areas where innovation is concentrated. The most active field was national health management, which includes systems for tracking public health trends and managing chronic diseases at a population level. This was followed by general medical services and medical robotics, which covers the development of surgical and interventional robots. These areas have seen a massive surge in activity, particularly in the last five years of the study. However, when the researchers looked at the application of these technologies to Traditional Chinese Medicine, the picture was starkly different. Patents related to intelligent systems for Chinese medicine made up only a tiny fraction of the total. The few inventions that did exist were mostly simple improvements to hardware, like better pulse-taking devices, while the complex task of using artificial intelligence to interpret the subtle signs of Chinese medicine diagnosis remained largely untouched.
Over the two decades studied, the focus of the industry has shifted noticeably. In the beginning, the work was almost entirely about building basic monitoring devices and improving traditional diagnostic tools. As time went on, the focus moved toward connecting these devices to the internet, creating systems for remote diagnosis, and using artificial intelligence to help doctors read medical images. The most recent years show a strong push toward telemedicine and AI-assisted decision-making, suggesting that the industry is finally beginning to integrate the digital and physical worlds. Yet, despite this progress, significant gaps remain. The researchers noted that areas like medical insurance management and pharmaceutical services have very few patents, indicating that the smart healthcare revolution has not yet reached every corner of the medical system.
The study concludes that while China has built a massive engine for innovation in smart healthcare, the machine is not yet perfectly balanced. It is heavy on hardware and light on the sophisticated algorithms that could make the system truly intelligent. It is strong in general medical services but weak in specialized areas like Chinese medicine and insurance management. To move forward, the researchers suggest that the focus needs to shift. They recommend creating better ways to share medical data securely so that artificial intelligence can learn from real-world cases, investing more in the foundational software that powers these systems, and finding new ways to encourage doctors and hospitals to participate in the invention process. Only by addressing these structural gaps can the full potential of smart healthcare be realized, turning a collection of clever devices into a truly integrated and intelligent system for human well-being.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.